MET mutation associated with responsiveness to crizotinib

Saiama N. Waqar; Daniel Morgensztern; Jennifer Sehn

doi:10.1097/JTO.0000000000000478

MET mutation associated with responsiveness to crizotinib

Saiama N. Waqar, Daniel Morgensztern, Jennifer Sehn

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	e29-e31
Journal	Journal of Thoracic Oncology
Volume	10
Issue number	5
DOIs	https://doi.org/10.1097/JTO.0000000000000478
State	Published - May 30 2015

Access to Document

10.1097/JTO.0000000000000478

Cite this

@article{18d56779988b42b6ac46dab6b6c79c37,

title = "MET mutation associated with responsiveness to crizotinib",

author = "Waqar, {Saiama N.} and Daniel Morgensztern and Jennifer Sehn",

note = "Funding Information: This study was made possible by Grant Number 1K12CA167540 through the National Cancer Institute (NCI) at the National Institutes of Health (NIH) and Grant Number UL1 TR000448 through the Clinical and Translational Science Award (CTSA) program of the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NCI, NCATS or NIH.",

year = "2015",

month = may,

day = "30",

doi = "10.1097/JTO.0000000000000478",

language = "English",

volume = "10",

pages = "e29--e31",

journal = "Journal of Thoracic Oncology",

issn = "1556-0864",

number = "5",

}

TY - JOUR

T1 - MET mutation associated with responsiveness to crizotinib

AU - Waqar, Saiama N.

AU - Morgensztern, Daniel

AU - Sehn, Jennifer

N1 - Funding Information: This study was made possible by Grant Number 1K12CA167540 through the National Cancer Institute (NCI) at the National Institutes of Health (NIH) and Grant Number UL1 TR000448 through the Clinical and Translational Science Award (CTSA) program of the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NCI, NCATS or NIH.

PY - 2015/5/30

Y1 - 2015/5/30

UR - http://www.scopus.com/inward/record.url?scp=84938222817&partnerID=8YFLogxK

U2 - 10.1097/JTO.0000000000000478

DO - 10.1097/JTO.0000000000000478

M3 - Letter

C2 - 25898962

AN - SCOPUS:84938222817

SN - 1556-0864

VL - 10

SP - e29-e31

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

IS - 5

ER -

MET mutation associated with responsiveness to crizotinib

Access to Document

Other files and links

Cite this